Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
- PMID: 34088334
- PMCID: PMC8177256
- DOI: 10.1186/s13045-021-01100-7
Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
Abstract
Cases of thrombotic thrombocytopenia induced by coronavirus disease 2019 (COVID-19) vaccines have been reported recently. Herein, we describe the first case of another critical disorder, hemophagocytic lymphohistiocytosis (HLH), in a healthy individual after COVID-19 vaccination. A 43-year-old Chinese farmer developed malaise, vomiting, and persistent high fever (up to 39.7 °C) shortly after receiving the first dose of the inactivated SARS-CoV-2 vaccine. The initial evaluation showed pancytopenia (neutrophil count, 0.70 × 109/L; hemoglobin, 113 g/L; platelet, 27 × 109/L), elevated triglyceride (2.43 mmol/L), and decreased fibrinogen (1.41 g/L). Further tests showed high serum ferritin levels (8140.4 μg/L), low NK cell cytotoxicity (50.13%-60.83%), and positive tests for Epstein-Barr virus (EBV) DNA. Hemophagocytosis was observed in the bone marrow. Therefore, HLH was confirmed, and dexamethasone acetate (10 mg/day) was immediately prescribed without etoposide. Signs and abnormal laboratory results resolved gradually, and the patient was discharged. HLH is a life-threatening hyperinflammatory syndrome caused by aberrantly activated macrophages and cytotoxic T cells, which may rapidly progress to terminal multiple organ failure. In this case, HLH was induced by the COVID-19 vaccination immuno-stimulation on a chronic EBV infection background. This report indicates that it is crucial to exclude the presence of active EBV infection or other common viruses before COVID-19 vaccination.
Keywords: COVID-19; Coagulopathy; Epstein–Barr virus; Hemophagocytic lymphohistiocytosis; SARS-CoV-2 vaccine.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
A case of hemophagocytic lymphohistiocytosis after BNT162b2 COVID-19 (Comirnaty®) vaccination.Medicine (Baltimore). 2022 Oct 28;101(43):e31304. doi: 10.1097/MD.0000000000031304. Medicine (Baltimore). 2022. PMID: 36316859 Free PMC article.
-
Pediatric hemophagocytic lymphohistiocytosis after concomitant administration of SARS-CoV-2 vaccine and influenza vaccine.J Infect Chemother. 2024 Jan;30(1):67-70. doi: 10.1016/j.jiac.2023.08.015. Epub 2023 Aug 30. J Infect Chemother. 2024. PMID: 37657516
-
Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.Infection. 2022 Oct;50(5):1399-1404. doi: 10.1007/s15010-022-01786-y. Epub 2022 Feb 26. Infection. 2022. PMID: 35218512 Free PMC article.
-
A case of Hemophagocytic lymphohistiocytosis induced by COVID-19, and review of all cases reported in the literature.J Infect Dev Ctries. 2021 Nov 30;15(11):1607-1614. doi: 10.3855/jidc.14829. J Infect Dev Ctries. 2021. PMID: 34898486 Review.
-
Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma: A case report and literature review.Medicine (Baltimore). 2020 Sep 25;99(39):e22299. doi: 10.1097/MD.0000000000022299. Medicine (Baltimore). 2020. PMID: 32991435 Free PMC article. Review.
Cited by
-
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24. J Autoimmun. 2022. PMID: 36041291 Free PMC article. Review.
-
Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders.Best Pract Res Clin Haematol. 2022 Sep;35(3):101375. doi: 10.1016/j.beha.2022.101375. Epub 2022 Aug 24. Best Pract Res Clin Haematol. 2022. PMID: 36494144 Free PMC article. Review.
-
Corona Virus Disease-19 Vaccine-associated Autoimmune Disorders.Rheumatol Immunol Res. 2022 Oct 20;3(3):111-119. doi: 10.2478/rir-2022-0019. eCollection 2022 Oct. Rheumatol Immunol Res. 2022. PMID: 36788969 Free PMC article. Review.
-
Hemophagocytic Lymphohistiocytosis for the Internist and Other Primary Care Providers.J Prim Care Community Health. 2021 Jan-Dec;12:21501327211053756. doi: 10.1177/21501327211053756. J Prim Care Community Health. 2021. PMID: 34704505 Free PMC article. Review.
-
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.Int J Mol Sci. 2022 Mar 19;23(6):3338. doi: 10.3390/ijms23063338. Int J Mol Sci. 2022. PMID: 35328761 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous